May 3, 2024
More women today are surviving breast cancer if it’s caught early, largely because of better screening and more effective and targeted treatments. However, not everyone has […]
May 2, 2024
British investigators have demonstrated a “potentially curative” neoadjuvant regimen for early-stage germline BRCA 1/2–mutated breast cancer. In a small trial, 39 patients randomized to the regimen […]
May 1, 2024
NEW YORK(Reuters) – Johnson & Johnson said on Wednesday it is moving forward with a $6.48 billion proposed settlement of tens of thousands of lawsuits alleging […]
May 1, 2024
Hysteroscopy is a crucial examination for the diagnosis of endometrial cancer. In Brazil, women with postmenopausal bleeding who need to undergo this procedure in the public […]
April 30, 2024
Women who are considered to be at average risk for breast cancer should have mammograms every other year starting at age 40 years until age 74, […]
April 30, 2024
Adjuvant therapy with aspirin offers no protection against recurrence or survival benefit in patients with high-risk nonmetastatic breast cancer, the results of a new phase 3 […]
April 30, 2024
Stereotactic radiosurgery appears to be feasible, safe, and effective for patients with 15 or more brain metastases and may be a viable alternative to whole brain […]
April 29, 2024
TOPLINE: Immune checkpoint inhibitors (ICIs) are now widely used immunotherapies for many cancers, but their use in pregnancy is discouraged because of the lack of safety […]
April 26, 2024
The European Medicines Agency (EMA) this week recommended granting a marketing authorization for Altuvoct (efanesoctocog alfa) for the treatment and prophylaxis of bleeding in patients with hemophilia […]